Trade Mark Journal No.2025/051 19 December 2025

WO0000001877243 (5,10,42)

Office of origin: United States of America

Date of International Registration:21 August 2025
Date of designation in the UK: 21 August 2025
Image for mark 1877243

The mark consists of "TIDEWAVE BI" in block font followed by an "O" shape where the bottom half is solid and the top half is transparent with small circles of various sizes. The two halves are separated by a wavy line.

International priority date claimed: 21 February 2025 (United States of America) (99050569)
Class 5
Pharmaceutical preparations for the treatment of solid tumors; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of neurogenerative diseases; pharmaceutical preparations for the treatment of chronic inflammatory diseases; vaccines; therapeutic vaccines; therapeutic vaccines for solid tumors; diagnostic kits comprising diagnostic agents, preparations and substances for medical use.
Class 10
Medical devices for use in treating solid tumors; medical devices for diagnosis of solid tumors and matching liquid biopsy.
Class 42
Vaccine research and development; research and development of pharmaceuticals for solid tumors.

Tidewave Biotech, Inc.

Representative: Alexis Crawford Douglas K&L Gates LLP, P.O. BOX 1135, Chicago IL 60690-1135, UNITED STATES OF AMERICA